Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The treatment of adults with acute lymphoblastic leukemia.

The treatment of adults with acute lymphoblastic leukemia. Despite the relatively low incidence of acute lymphoblastic leukemia (ALL) in adults, large national and international collaborations have recently improved our understanding of how to treat ALL in adults. This article documents and examines the current evidence base for a "state of the art" therapy in both Philadelphia chromosome-negative and -positive adult ALL. The article comments upon areas of therapeutic debate, such as the role of bone marrow transplantation. In particular, the controversial subject of whether the superior outcome seen in younger patients is predicated on disease biology or therapeutic strategy is examined closely. Promising approaches under development are also discussed. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Hematology Pubmed

The treatment of adults with acute lymphoblastic leukemia.

Hematology : -371 – Jul 28, 2009

The treatment of adults with acute lymphoblastic leukemia.


Abstract

Despite the relatively low incidence of acute lymphoblastic leukemia (ALL) in adults, large national and international collaborations have recently improved our understanding of how to treat ALL in adults. This article documents and examines the current evidence base for a "state of the art" therapy in both Philadelphia chromosome-negative and -positive adult ALL. The article comments upon areas of therapeutic debate, such as the role of bone marrow transplantation. In particular, the controversial subject of whether the superior outcome seen in younger patients is predicated on disease biology or therapeutic strategy is examined closely. Promising approaches under development are also discussed.

Loading next page...
 
/lp/pubmed/the-treatment-of-adults-with-acute-lymphoblastic-leukemia-BnPwfd8H0x

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1520-4391
DOI
10.1182/asheducation-2008.1.381
pmid
19074114
Publisher site
See Article on Publisher Site

Abstract

Despite the relatively low incidence of acute lymphoblastic leukemia (ALL) in adults, large national and international collaborations have recently improved our understanding of how to treat ALL in adults. This article documents and examines the current evidence base for a "state of the art" therapy in both Philadelphia chromosome-negative and -positive adult ALL. The article comments upon areas of therapeutic debate, such as the role of bone marrow transplantation. In particular, the controversial subject of whether the superior outcome seen in younger patients is predicated on disease biology or therapeutic strategy is examined closely. Promising approaches under development are also discussed.

Journal

HematologyPubmed

Published: Jul 28, 2009

There are no references for this article.